Grace Mendoza

Title: The Innovative Contributions of Grace Mendoza in Glycosyltransferase Research

Introduction

Grace Mendoza, an accomplished inventor based in San Diego, CA, has made significant strides in the field of biotechnology with her innovative contributions. As an employee of Neose Technologies, Inc., she has been at the forefront of research, focusing on the development of recombinant glycosyltransferase fusion proteins. Her work exemplifies the intersection of scientific advancement and practical application.

Latest Patents

Grace Mendoza holds a patent for her invention titled "Fucosyltransferase fusion protein." This groundbreaking invention provides recombinant glycosyltransferase fusion proteins that exhibit a desired level of expression and enzymatic activity, including specific acceptor substrate specificity and catalytic activity. The unique design of these fusion proteins incorporates a functional domain from a first glycosyltransferase, connected either directly or via a peptide linker to a subsequence of a functional domain from a second glycosyltransferase. Additionally, the patent encompasses nucleic acids that encode the fusion proteins, host cells for expressing them, and methods for producing and utilizing these innovative proteins.

Career Highlights

Throughout her career, Grace Mendoza has demonstrated an unwavering commitment to advancing biotechnological research. Her sole patent speaks to her innovative capabilities and strong dedication to her work at Neose Technologies, Inc. Working within a collaborative environment, she has contributed to projects that can potentially redefine therapeutic approaches within the biotechnology sector.

Collaborations

At Neose Technologies, Inc., Grace collaborates closely with her colleague Robert J Bayer. Together, they explore new frontiers in glycosylation and protein engineering, working towards innovations that could lead to enhanced biological therapies. Their partnership reflects a shared vision in the quest for groundbreaking solutions in the field.

Conclusion

Grace Mendoza's contributions to the development of fucosyltransferase fusion proteins underscore her role as a pivotal figure in the biotechnology landscape. Her patent highlights the potential applications of her work that could revolutionize how glycosyltransferases are utilized in various therapeutic contexts. Through her career at Neose Technologies, Inc., and her collaboration with peers, she continues to drive innovation and inspire future advancements in the field.